View in Other Languages

MMJ PhytoTech Ltd

ASX:MMJ ISIN:AU000000MMJ4

Phytotech Medical ASX:PYL

In October 2017, MMJ PhytoTech Limited (ASX:MMJ) announced its strategy to become an incubator for strategic investments across regulated jurisdictions globally covering the entire cannabis value chain.

Following the successful listing of United Greeneries Holdings Ltd ("United Greeneries") and Satipharm AG ("Satipharm") on the TSX-V through Harvest One Cannabis Inc. (CVE:HVST), MMJ has focused on the identification of a number of independent strategic investment opportunities that have the potential to deliver significant value to the Company's shareholders.

MMJ is actively pursuing early stage opportunities with the ability to deliver significant future revenue and the opportunity to provide dramatic global synergistic value as regulatory frameworks in key international markets continue to evolve. MMJ is targeting the full range of emerging cannabis-related sectors including healthcare products, technology, infrastructure, logistics, processing, cultivation, equipment, R&D, hemp food products and retail.

MMJ currently holds an equity stake of 53,333,333 shares in Harvest One, 100% ownership of Israeli-based R&D division PhytoTech Therapeutics Limited ("PTL") and strategic holdings in e-Sense Lab Limited (ASX:ESE) and private Canadian-based company WeedMe Inc.

       

News

MMJ PhytoTech Ltd (ASX:MMJ) Harvest One (CVE:HVST) Operational Update

🕔12/19/2017 8:22:27 AM 2180

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that TSX-V listed Harvest One Cannabis Inc. (CVE:HVST), which is 59% owned by MMJ, has released an operational update on its wholly-owned horticultural subsidiary United Greeneries Ltd.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Expands Canadian Cannabis Footprint via Strategic Investment in Late-Stage ACMPR Applicant Weed Me Inc.

🕔12/12/2017 10:13:42 AM 3274

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that it has entered into an agreement to strengthen its position in the Canadian cannabis sector via the proposed subscription of C$2 million in secured convertible debentures in Toronto-based Weed Me Inc.. The Debentures are convertible into shares and warrants in Weed Me based on a pre-money valuation of C$10 million.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) PhytoTech Therapeutics Ltd Management Changes

🕔12/1/2017 9:33:01 AM 1870

MMJ PhytoTech Limited (ASX:MMJ) wishes to advise that Dr Daphna Heffetz, Chief Executive Officer of the Company's 100%-owned Israeli-based subsidiary PhytoTech Therapeutics Limited, has tendered her resignation. Dr Heffetz will remain in her current role until 31 December 2017.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Harvest One (CVE:HVST) Financing Update

🕔11/22/2017 9:45:31 AM 2004

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that TSX-V listed Harvest One Cannabis Inc. (CVE:HVST), which is 59% owned by MMJ, has released an update in relation to the financing agreement entered into with Mackie Research Capital Corporation.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Harvest One (CVE:HVST) Financing Update

🕔11/21/2017 1:57:04 PM 2063

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that TSX-V listed Harvest One Cannabis Inc. (CVE:HVST), which is 59% owned by MMJ, has released a corporate update in regards to a financing agreement entered into with Mackie Research Capital Corporation.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Harvest One (CVE:HVST) Operational Update

🕔11/21/2017 9:43:28 AM 1842

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that TSX-V listed Harvest One Cannabis Inc. (CVE:HVST), which is 59% owned by MMJ, has released an operational update on its horticultural division United Greeneries Ltd.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Phase 1 Clinical Trial Results Published in International Medical Journal

🕔11/16/2017 9:40:55 AM 1962

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that results from the Phase 1 Clinical Trial undertaken by MMJ's wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Ltd have been published.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Harvest One Operational Update

🕔11/15/2017 9:33:55 AM 1919

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that TSX-V listed Harvest One Cannabis Inc. (CVE:HVST), which is 59% owned by MMJ, has released an operational update on its medical and health division Satipharm AG.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Commits A$500,000 Cornerstone Investment in eSense-Lab Limited (ASX:ESE)

🕔11/14/2017 9:53:51 AM 3031

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that it has agreed to invest A$500,000 in ASX listed Israeli life sciences company eSense-Lab Limited (ASX:ESE).

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Quarterly Update and Appendix 4C

🕔11/1/2017 9:07:09 AM 1880

MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide its quarterly activities report for the period ended 30 September 2017, together with its Appendix 4C.

Read Full Article
###

50,508 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 288) (Last 30 Days: 1893) (Since Published: 38437) 

Markets ASX:MMJ

Company Data

    Headquarters
  • Suite 5 CPC, 145 Stirling Highway
    Nedlands WA 6009
    Australia
  • Telephone
  • +61-8-9389-3150 
  • Fax
  • +61-8-9389-3199 
  • Principal Sector
  • Ag Biotechnology 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.mmjphytotech.com.au
  • E:
  • info@mmjphytotech.com.au

Company Reports

Presentations

Research Report

Quarterly Report

Social Media